Absorption of coptisine chloride and berberrubine across human intestinal epithelial by using human Caco-2 cell monolayers

Zhongguo Zhongyao Zazhi

Volumn 32, Issue 23, 2007, Pages 2523-2527

  Ma, Lian ^a   Yang, Xiu Wei ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Apparent permeability coefficients; Berberrubine; Caco 2 cell monolayer; Coptisine chloride; Intestinal absorption

Indexed keywords

BERBERINE; BEROLINE; COPTISINE; DRUG DERIVATIVE;

ABSORPTION; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CHEMISTRY; CORYDALIS; EPITHELIUM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METABOLISM; METHODOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ABSORPTION; BERBERINE; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORYDALIS; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; PLANTS, MEDICINAL;

EID: 38549177959     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Chinese source
2. Chinese source
3. Chinese source
4. Chinese source
5. Yee SY. In vitro permeability across Caco-2 cells (colonic) can predict in vivo ( small intestinal) absorption in man-fact or myth [J]. Pharm Res, 1997,14(6) :763.
6. Chong S, Dando S A, Morrison R A. Evaluation of biocoat intestinal epithelium differentiation environment (3-day cultured Caco-2 cells) as an absorption screening model with improved productivity[J]. Pharm Res, 1997,14(12) :1835.
7. Gao JN, Hugger E D, Beck-Westermeyer M S, et al. Estimating intestinal mucosal permeation of compounds using Caco-2 cell monolayer. In : Current protocols in pharmacology. [M]. Chichester:John Wiley & Sons,2000:721.
8. Walle U K, French K L, Walgren R A, et al. Transport of genistein-7-glucoside by human intestinal Caco-2 cells : Potential role for MRP2[J]. Res Com Mol Pathol Pharmacol, 1999, 103 (1):45.
9. Kobayashi Y, Yamashita Y, Fujii N, et al. Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes[ J]. Planta Med, 1995,61(5) :414.
10. Park K D, Lee J H, Kim S H, et al. Synthesis of 13-(substituted benzyl) berberine and berberrubine derivatives as antifungal agents[J]. Bioorg Med Chem Lett, 2006, 16(15) :3913.
11. Cui H S, Hayasaka S, Zhang X Y, et al. Effect of berberrubine on interleukin-8 and monocyte chemotactic protein-1 expression in human retinal pigment epithelial cell line[ J]. Life Sci, 2006, 79 (10) :949.
12. α in human colorectal carcinoma cells resistant to a protoberberine alkaloid, berberrubine[ J]. Mol Pharmacol, 2002, 61 (4) : 879.
13. Kim S A, Kwon Y, Kim J H, et al. Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine[J]. Biochem, 1998, 37(46) :16316.
14. Iwasa K, Kamigauch M, Ueki M, et al. Antibacterial activity and structure-activity relationships of berfaerine analogs [ J]. Eur J Med Chem, 1996,31(6) :469.
15. Chen W H, Pang J Y, Qui Y, et al. Synthesis of linked berberine dimers and their remarkably enhanced DNA-binding affinities [J]. Bioorg Med Chem Lett, 2005,15(10) :2689.
16. Zuo F, Nakamura N, Akao T, et al. Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry[J]. Drug Metabo Dispos, 2006, 34(12) :2064.
17. Li H L, Zhang W D, Zhang C, et al. Bioavailability and pharmacokinetics of four active alkaloids of traditional Chinese medicine Yanhuanglian in rats following intravenous and oral administration[J]. J Pharm Biomed Anal, 2006, 41(4) :1342.
18. Chinese source